No Data
No Data
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Corporate presentation scheduled for Monday, June 3, 2024 at 2:30 P.M. PDT CARMIEL, Israel, May 29, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical compa
Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript
Earnings Call Summary | Protalix Biotherapeutics(PLX.US) Q1 2024 Earnings Conference
The following is a summary of the Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript:Financial Performance:Protalix BioTherapeutics reported decreased revenues from goods sales to $
Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript
Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript
No Data